Sandoz To Market “Authorized” Generic Of J&J Duragesic
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is reviewing the merits of citizen petitions regarding approval of generic fentanyl transermal patches, Johnson & Johnson Worldwide Chairman Poon says. The company recommends that investors model greater impact from Duragesic and Concerta generics beyond the first quarter.